These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 11528545)

  • 1. Getting into dementia assessment on the "ground floor".
    Steinberg BA
    Clin Neuropsychol; 2001 May; 15(2):235-9. PubMed ID: 11528545
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuropsychological assessment in chronic care settings: potential utility and special considerations for evaluating dementia in the elderly.
    Perlick D; Mattis S
    Alzheimer Dis Assoc Disord; 1994; 8 Suppl 1():S209-13. PubMed ID: 8068261
    [No Abstract]   [Full Text] [Related]  

  • 3. Dementia staging in chronic care populations.
    Reisberg B; Sclan SG; Franssen E; Kluger A; Ferris S
    Alzheimer Dis Assoc Disord; 1994; 8 Suppl 1():S188-205. PubMed ID: 8068258
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic problems in nursing home patients with dementia: why we should and how we can improve accuracy.
    Mayeux R
    Alzheimer Dis Assoc Disord; 1994; 8 Suppl 1():S184-7. PubMed ID: 8068257
    [No Abstract]   [Full Text] [Related]  

  • 5. [The reliability of a brief psychological performance test for detection of acquired impaired performance. Exemplified by the Lehrl and Fischer c. I. test].
    Gress-Heister M
    Nervenarzt; 1994 Aug; 65(8):575-6. PubMed ID: 7969659
    [No Abstract]   [Full Text] [Related]  

  • 6. Improving office detection of asymptomatic dementia.
    Raab MF; Anstadt SP
    J Am Geriatr Soc; 2011 Oct; 59(10):1975-6. PubMed ID: 22091518
    [No Abstract]   [Full Text] [Related]  

  • 7. Individual trajectories as the starting point for longitudinal data analysis.
    Rogosa D
    Alzheimer Dis Assoc Disord; 1994; 8 Suppl 1():S302-7. PubMed ID: 8068273
    [No Abstract]   [Full Text] [Related]  

  • 8. Latent structure methods for estimating item bias, item validity and prevalence using cognitive and other geriatric screening measures.
    Teresi JA; Golden RR
    Alzheimer Dis Assoc Disord; 1994; 8 Suppl 1():S291-8. PubMed ID: 8068271
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential cultural bias in the neuropsychological assessment of the older adult.
    Loewenstein DA; Argüelles T; Argüelles S; Linn-Fuentes P
    J Clin Exp Neuropsychol; 1994 Aug; 16(4):623-9. PubMed ID: 7962363
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuropsychological characteristics of the dementia syndrome of depression: onset, resolution, and three-year follow-up.
    McNeil JK
    Clin Neuropsychol; 1999 May; 13(2):136-46. PubMed ID: 10949155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The test for severe impairment: validity with the Dementia Rating Scale and utility as a longitudinal measure.
    Foldi NS; Majerovitz SD; Sheikh K; Rodriguez E
    Clin Neuropsychol; 1999 Feb; 13(1):22-9. PubMed ID: 10937645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Ferris SH; Lucca U; Mohs R; Dubois B; Wesnes K; Erzigkeit H; Geldmacher D; Bodick N
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():34-8. PubMed ID: 9305514
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comment on the letter by M. Gress-Heister regarding the contribution by H. Wolfram and J. Pausch. On the value of the brief psychological performance test for detection of acquired impairments. Exemplified by the Lehrl and Fischer c. I. Test].
    Wolfram H
    Nervenarzt; 1995 Jun; 66(6):479. PubMed ID: 7637836
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuropsychological detection of dementia: an overview of the neuropsychological component of the Canadian Study of Health and Aging.
    Tuokko H; Kristjansson E; Miller J
    J Clin Exp Neuropsychol; 1995 May; 17(3):352-73. PubMed ID: 7650099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comments on measurement of severe dementia.
    Zandi T
    Alzheimer Dis Assoc Disord; 1994; 8 Suppl 1():S206-8. PubMed ID: 8068260
    [No Abstract]   [Full Text] [Related]  

  • 16. National Institute on Aging collaborative studies in the standardization of cognitive measures.
    Buckholtz NS; Radebaugh TS
    Alzheimer Dis Assoc Disord; 1994; 8 Suppl 1():S214-6. PubMed ID: 8068262
    [No Abstract]   [Full Text] [Related]  

  • 17. Japanese version of the Frontal Assessment Battery for dementia.
    Kugo A; Terada S; Ata T; Ido Y; Kado Y; Ishihara T; Hikiji M; Fujisawa Y; Sasaki K; Kuroda S
    Psychiatry Res; 2007 Sep; 153(1):69-75. PubMed ID: 17599465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Measuring cognitive change in patients with suspected dementia--change norms are lacking for psychometric instruments].
    Hensel A; Riedel-Heller SG
    Psychiatr Prax; 2008 Jul; 35(5):251-4. PubMed ID: 17806007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of the NEPSY: a developmental neuropsychological assessment.
    Ahmad SA; Warriner EM
    Clin Neuropsychol; 2001 May; 15(2):240-9. PubMed ID: 11530782
    [No Abstract]   [Full Text] [Related]  

  • 20. Systemic lupus erythematosus and dementia.
    Croake JW; Pursley M; Hardin JG; Michalski JP
    Psychol Rep; 1998 Dec; 83(3 Pt 1):1034. PubMed ID: 9923182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.